Miércoles IDIS (20/05/2026)
«Nanocarriers combine active and endogenous targeting to enable in vivo siRNA delivery for KRAS-dependent lung cancer treatment» by Philipp Lapuhs (C025 – Nanobiofar) «Metabolic glycoengineering-guided clickable nanoemulsions for selective targeting […]